EcoDrugPlus

Adenosine A2a Receptor

Ensembl ID : ENSEEEG00000018025
Gene Symbol: ADORA2A
4 Cross references
200 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSEEEG00000006897
Gene Symbol: ADORA2B
4 Cross references
199 Possible Orthologues:

Adenosine A3 Receptor

Ensembl ID : ENSEEEG00000007194
Gene Symbol: ADORA3
4 Cross references
221 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSEEEG00000023790
Gene Symbol: ADA
4 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 1aa

Ensembl ID : ENSEEEG00000010130
Gene Symbol: ADRA1AA
4 Cross references
202 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSEEEG00000020688
Gene Symbol: ADRA1B
4 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 1bb

Ensembl ID : ENSEEEG00000007243
Gene Symbol: ADRA1BB
4 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSEEEG00000012100
Gene Symbol: ADRA1D
4 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSEEEG00000010590
Gene Symbol: ADRA2A
4 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSEEEG00000023452
Gene Symbol: ADRA2B
4 Cross references
211 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSEEEG00000004025
Gene Symbol: ADRA2C
2 Cross references
156 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSEEEG00000013942
Gene Symbol: ADRA2C
4 Cross references
162 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).